Published in J Pharm Pharmacol on December 01, 1983
Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants. Br J Pharmacol (1985) 1.23
Responses to the beta 2-selective agonist procaterol of vascular and atrial preparations with different functional beta-adrenoceptor populations. Br J Pharmacol (1985) 1.18
Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues. Br J Pharmacol (1987) 1.18
Effects of selective alpha 1-, alpha 2-, beta 1-and beta 2-adrenoceptor stimulation on potentials and contractions in the rabbit heart. J Physiol (1984) 0.99
The in vitro pharmacology of xamoterol (ICI 118,587). Br J Pharmacol (1985) 0.97
Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects. Br J Pharmacol (1989) 0.86
Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline. Br J Pharmacol (1992) 0.80
Beta-adrenoceptor blocking effects of a selective beta 2-agonist, mabuterol, on the isolated, blood-perfused right atrium of the dog. Br J Pharmacol (1989) 0.77
The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat. Br J Pharmacol (1986) 0.75
Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science (1984) 3.63
Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron (1993) 3.44
Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene. Science (1984) 3.24
Controls of RNA splicing and termination in the major late adenovirus transcription unit. Nature (1981) 2.49
Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1977) 2.26
Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron (1990) 2.22
Synthesis of a structural adenovirus polypeptide in the absence of viral DNA replication. Virology (1978) 2.09
Coexpression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth. Cell (1985) 2.06
Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron (1991) 2.02
Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci U S A (1990) 1.94
Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc Natl Acad Sci U S A (1978) 1.94
Adenovirus early gene products may control viral mRNA accumulation and translation in vivo. Cell (1981) 1.93
Synthesis and genomic site for an adenovirus type 2 early glycoprotein. J Mol Biol (1980) 1.82
Myelinated nerve fibres in the CNS. Prog Neurobiol (1993) 1.79
Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol (1993) 1.78
Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron (1991) 1.74
Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia (2007) 1.73
A study of 136 cases of adder bite treated in Swedish hospitals during one year. Acta Med Scand (1981) 1.71
Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science (1995) 1.70
Viral DNA sequences and gene products in hamster cells transformed by adenovirus type 2. J Virol (1978) 1.69
Control of adenovirus early gene expression: posttranscriptional control mediated by both viral and cellular gene products. Mol Cell Biol (1981) 1.68
Multiple mRNA species for the precursor to an adenovirus-encoded glycoprotein: identification and structure of the signal sequence. Proc Natl Acad Sci U S A (1980) 1.66
Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell (1992) 1.62
An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse. Nature (1982) 1.60
Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci U S A (1986) 1.56
Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience (1992) 1.52
Gene and mRNA for precursor polypeptide VI from adenovirus type 2. J Virol (1981) 1.49
Pharmacological properties of 1-(3'5'-diisobutyryloxy-phenyl)-2-(t-butylamino)-ethanolhydrochloride (KWD 2058), a new sympathomimetic bronchodilator. Acta Pharmacol Toxicol (Copenh) (1974) 1.42
Purification and characterization of an early glycoprotein from adenovirus type 2-infected cells. J Virol (1979) 1.39
Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp Neurol (1990) 1.37
2 new groups of selective stimulants of adrenergic beta-receptors. Experientia (1969) 1.36
Expression of the beta-nerve growth factor gene in hippocampal neurons. Science (1988) 1.35
Purification of a native membrane-associated adenovirus tumor antigen. J Virol (1982) 1.35
Growth-dependent synthesis of c-myc-encoded proteins: early stimulation by serum factors in synchronized mouse 3T3 cells. Mol Cell Biol (1985) 1.34
Citalopram toxicity. Lancet (1997) 1.32
Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci U S A (1992) 1.29
Expression of nerve growth factor receptor mRNA is developmentally regulated and increased after axotomy in rat spinal cord motoneurons. Neuron (1989) 1.28
p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron (1994) 1.28
Rat beta-nerve growth factor sequence and site of synthesis in the adult hippocampus. J Neurosci Res (1988) 1.27
Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail (2004) 1.26
Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci Lett (1992) 1.25
An extended surface of binding to Trk tyrosine kinase receptors in NGF and BDNF allows the engineering of a multifunctional pan-neurotrophin. EMBO J (1993) 1.25
Ethylene glycol poisoning: experiences from an epidemic in Sweden. J Toxicol Clin Toxicol (1992) 1.23
Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc Natl Acad Sci U S A (1993) 1.23
Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci U S A (1987) 1.22
Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res (1993) 1.20
Developmental and regional expression of beta-nerve growth factor receptor mRNA in the chick and rat. Neuron (1988) 1.20
Characterization of glial trkB receptors: differential response to injury in the central and peripheral nervous systems. Proc Natl Acad Sci U S A (1993) 1.19
B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor. Proc Natl Acad Sci U S A (1982) 1.19
Epidemiology of heart failure in Sweden--a national survey. Eur J Heart Fail (2001) 1.17
Regulation of adenovirus gene expression. Curr Top Microbiol Immunol (1982) 1.16
Developmental regulation of brain-derived neurotrophic factor messenger RNAs transcribed from different promoters in the rat brain. Neuroscience (1994) 1.15
Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J Neurosci (1992) 1.14
Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc Natl Acad Sci U S A (1993) 1.14
Structure of three spliced mRNAs from region E3 of adenovirus type 2. Gene (1983) 1.13
The pancreas transplant program--Gothenburg, Sweden. Transplant Proc (1987) 1.13
C-myc expression is dissociated from DNA synthesis and cell division in Xenopus oocyte and early embryonic development. EMBO J (1986) 1.13
Distinct functions for thyroid hormone receptors alpha and beta in brain development indicated by differential expression of receptor genes. EMBO J (1991) 1.13
The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation (1993) 1.12
A novel mRNA and a low molecular weight polypeptide encoded in the transforming region of adenovirus DNA. EMBO J (1982) 1.10
Purification and characterization of an early protein (E14K) from adenovirus type 2-infected cells. J Virol (1978) 1.09
Chimeric molecules with multiple neurotrophic activities reveal structural elements determining the specificities of NGF and BDNF. EMBO J (1991) 1.09
Increased levels of trkB mRNA and trkB protein-like immunoreactivity in the injured rat and cat spinal cord. Proc Natl Acad Sci U S A (1992) 1.08
Renal transplantation in the Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. Nephrol Dial Transplant (1991) 1.08
Some pharmacological properties of terbutaline (INN), 1-(3,5-dihydroxyphenyl)-2-(T-butylamino)-ethanol. A new sympathomimetic beta-receptor-stimulating agent. Acta Med Scand Suppl (1970) 1.08
Nerve growth factor mRNA and protein in the testis and epididymis of mouse and rat. Proc Natl Acad Sci U S A (1988) 1.08
Adrenergic and cholinesterase-containing neurons of the heart. Histochemie (1968) 1.07
Expression of members of the trk family in the developing postnatal rat brain. Brain Res Dev Brain Res (1993) 1.04
A maturation protein in adenovirus morphogenesis. Virology (1979) 1.04
Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants. Proc Natl Acad Sci U S A (1999) 1.04
Predicting readmissions and cardiovascular events in heart failure patients. Int J Cardiol (2005) 1.04
Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur J Neurosci (1993) 1.03
Identification of brain-derived neurotrophic factor promoter regions mediating tissue-specific, axotomy-, and neuronal activity-induced expression in transgenic mice. J Cell Biol (1995) 1.03
Diagnostic tests, treatment and follow-up in heart failure patients--is there a gender bias in the coherence to guidelines? Eur J Heart Fail (1999) 1.00
Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain. Exp Neurol (1991) 1.00
Control of adenovirus early gene expression: accumulation of viral mRNA after infection of transformed cells. J Virol (1981) 1.00
Limited long term effects of a management programme for heart failure. Heart (2004) 1.00
Regulation of neurotrophin and trkA, trkB and trkC tyrosine kinase receptor messenger RNA expression in kindling. Neuroscience (1993) 1.00
Control of adenovirus gene expression: cellular gene products restrict expression of adenovirus host range mutants in nonpermissive cells. J Virol (1983) 0.99
Coexistence and gene expression of phenylethanolamine N-methyltransferase, tyrosine hydroxylase, and neuropeptide tyrosine in the rat and bovine adrenal gland: effects of reserpine. Proc Natl Acad Sci U S A (1988) 0.99
Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.99
Structure and expression of the chicken beta nerve growth factor gene. EMBO J (1986) 0.97
Transient and persistent expression of NT-3/HDNF mRNA in the rat brain during postnatal development. J Neurosci (1991) 0.97
Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp Neurol (1993) 0.97
Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature (1994) 0.96
Neuropeptide tyrosine in the rat adrenal gland--immunohistochemical and in situ hybridization studies. Neuroscience (1988) 0.96
Analysis of transcriptional initiation and translatability of brain-derived neurotrophic factor mRNAs in the rat brain. Neurosci Lett (1994) 0.95
Citalopram overdose--review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol (1997) 0.95
Septal cholinergic afferents regulate expression of brain-derived neurotrophic factor and beta-nerve growth factor mRNA in rat hippocampus. Exp Brain Res (1992) 0.93
An adenovirus agnogene. Nucleic Acids Res (1982) 0.93
Expression of mRNAs for neurotrophin receptors in the dorsal root ganglion and spinal cord during development and following peripheral or central axotomy. Brain Res Mol Brain Res (1993) 0.93
Structure-function studies of nerve growth factor: functional importance of highly conserved amino acid residues. EMBO J (1990) 0.93
Histochemical and pharmacological studies on amine mechanisms in the umbilical cord, umbilical vein and ductus venosus of the human fetus. Acta Physiol Scand (1968) 0.92
Distribution of alcohol and sorbitol dehydrogenases. Assessment of mRNA species in mammalian tissues. Eur J Biochem (1993) 0.92
Effect of cholecystokinin on small intestine. Acta Physiol Scand (1967) 0.92
Detection of neuropeptide Y-like immunoreactivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells. Exp Cell Res (1991) 0.91
Neurotrophin-4 is a target-derived neurotrophic factor for neurons of the trigeminal ganglion. Development (1993) 0.91
A primary male autosomal linkage map of the horse genome. Genome Res (1998) 0.91
A DRB (5,6 dichloro-beta-D-ribofuranosylbenzimidazole)-resistant adenovirus mRNA. Nucleic Acids Res (1979) 0.90
Rapid increase of BDNF mRNA levels in cortical neurons following spreading depression: regulation by glutamatergic mechanisms independent of seizure activity. Brain Res Mol Brain Res (1993) 0.90